NCT06579547

Brief Summary

The goal of this clinical trial is to determine how effectively bone structures of the human skeleton can be visualized using Deep Learning (DL) augmented Magnetic Resonance Imaging (MRI) in individuals with inflammatory and degenerative joint changes, compared to Computed Tomography (CT). MRI is a technique that operates without the use of X-rays. The main question it aims to answer is:

  1. 1.Can DL MRI accurately depict bone structures as well as CT?
  2. 2.Can DL MRI be used as an alternative to CT to avoid exposure to X-rays in the future?
  3. 3.Undergo MRI scans of their skeletal system that will then be processed using DL.
  4. 4.Undergo CT scans of the same body region for comparison purposes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Aug 2024Jul 2026

Study Start

First participant enrolled

August 1, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

August 23, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

August 30, 2024

Status Verified

August 1, 2024

Enrollment Period

1.9 years

First QC Date

August 23, 2024

Last Update Submit

August 27, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Total score for bone erosions

    Each bone is scored separately. The scale is 0-10, based on the proportion of eroded bone compared to the "assessed bone volume," judged on all available images: 0: no erosion; 1: 1-10% of bone eroded; 2: 11-20%, etc. For long bones, the "assessed bone volume" is from the articular surface (or its best estimated position if absent) to a depth of 1 cm, while in carpal/tarsal bones it is the whole bone. Example of bone list for hands: carpal bones, distal radius, distal ulna, metacarpal bases; metacarpophalangeal, MCP, joints: metacarpal head, phalangeal base; maximum points: 230. A higher score means more bone erosions. Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.

    one day (day of MRI and CT examination)

  • Total score for joint space narrowing

    0: no narrowing, 1: focal or mild (\< 33%), 2: moderate (34-66%), 3: moderate to severe (67-99%), 4: ankylosis A higher score means more joint space narrowing. Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.

    one day (day of MRI and CT examination)

  • Visibility of cortical bone

    Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

    one day (day of MRI and CT examination)

  • Visibility of trabecular bone

    Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

    one day (day of MRI and CT examination)

  • Visibility of soft tissue calcifications

    Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

    one day (day of MRI and CT examination)

  • Contrast to noise ratio

    Average signal of erosion minus average signal of adjacent healthy bone, divided by the average background signal A higher score means better contrast of erosions when standardized for healthy adjacent bone and against the background.

    one day (day of MRI and CT examination)

  • Signal to noise ratio

    Average signal of erosion divided by the average background signal A higher score means better contrast of erosions against the background.

    one day (day of MRI and CT examination)

Interventions

Participants will undergo MRI scans of their skeletal system, followed by the Intervention of a Low Dose CT scan of the same body region for comparison purposes.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Referral for a clinically indicated MRI examination of the musculoskeletal system to assess inflammatory and degenerative joint changes.
  • Willingness to sign the informed consent form.
  • No contraindications for a CT examination (e.g., claustrophobia).

You may not qualify if:

  • No signed informed consent form.
  • Patients under 18 years of age.
  • Pregnant women.
  • The calculated effective dose of the CT examination exceeds 5 mSv.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich

Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Joint DiseasesArthritis

Condition Hierarchy (Ancestors)

Musculoskeletal Diseases

Central Study Contacts

Carina Obermüller, Dr. med.

CONTACT

Roman Guggenberger, PD Prof. Dr. med.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The radiologists who perform the readout will be blinded to the reference low dose CT scan to avoid being primed for certain bony anatomy and pathology by evaluating the low dose CT first. The reference low dose CT scan will be read in a separate session.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior Physician (Leitender Arzt)

Study Record Dates

First Submitted

August 23, 2024

First Posted

August 30, 2024

Study Start

August 1, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

August 30, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations